Medicina (Mar 2023)

A Systematic Review of Clinical Pharmacokinetics of Inhaled Antiviral

  • Mohammed Kanan Alshammari,
  • Mohammed Salem Almutairi,
  • Mohammed Dakhilallah Althobaiti,
  • Watin Ahmed Alsawyan,
  • Samar Abdulrahman Alomair,
  • Raghad Rsheed Alwattban,
  • Zahra Hassan Al Khozam,
  • Taif Jundi Alanazi,
  • Abdullah S. Alhuqyal,
  • Hassan Saud Al Darwish,
  • Abdulaziz Faisal Alotaibi,
  • Fahad Naif Almutairi,
  • Abdullah Abdulrahman Alanazi

DOI
https://doi.org/10.3390/medicina59040642
Journal volume & issue
Vol. 59, no. 4
p. 642

Abstract

Read online

Background and Objectives: The study of clinical pharmacokinetics of inhaled antivirals is particularly important as it helps one to understand the therapeutic efficacy of these drugs and how best to use them in the treatment of respiratory viral infections such as influenza and the current COVID-19 pandemic. The article presents a systematic review of the available pharmacokinetic data of inhaled antivirals in humans, which could be beneficial for clinicians in adjusting doses for diseased populations. Materials and Methods: This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. A comprehensive literature search was conducted using multiple databases, and studies were screened by two independent reviewers to assess their eligibility. Data were extracted from the eligible studies and assessed for quality using appropriate tools. Results: This systematic review evaluated the pharmacokinetic parameters of inhaled antiviral drugs. The review analyzed 17 studies, which included Zanamivir, Laninamivir, and Ribavirin with 901 participants, and found that the non-compartmental approach was used in most studies for the pharmacokinetic analysis. The outcomes of most studies were to assess clinical pharmacokinetic parameters such as the Cmax, AUC, and t1/2 of inhaled antivirals. Conclusions: Overall, the studies found that the inhaled antiviral drugs were well tolerated and exhibited favorable pharmacokinetic profiles. The review provides valuable information on the use of these drugs for the treatment of influenza and other viral respiratory infections.

Keywords